Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
6.71M
-
Shares change
-
+2.34M
-
Total reported value, excl. options
-
$39.3M
-
Value change
-
+$30.2M
-
Put/Call ratio
-
0.28
-
Number of buys
-
64
-
Number of sells
-
-2
-
Price
-
$5.86
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q2 2019
82 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q2 2019.
NOVAVAX INC - Common Stock (NVAX) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.71M shares
of 160M outstanding shares and own 4.19% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.79M shares), VANGUARD GROUP INC (1.4M shares), MORGAN STANLEY (654K shares), STATE STREET CORP (410K shares), GEODE CAPITAL MANAGEMENT, LLC (343K shares), NORTHERN TRUST CORP (237K shares), TWO SIGMA ADVISERS, LP (185K shares), Rock Springs Capital Management LP (163K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (119K shares), and Bank of New York Mellon Corp (103K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.